Your browser doesn't support javascript.
loading
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
Tammemägi, Martin Carl; Cina, Kristin; Kitts, Andrea K Borondy; Koop, David; Petereit, Mark A; Sargent, Michele; Petereit, Daniel G.
Affiliation
  • Tammemägi MC; Department of Health Sciences, Brock University, St Catharines, Ontario, Canada.
  • Cina K; Avera Research Institute, Rapid City, South Dakota, USA.
  • Kitts AKB; Rescue Lung Society, Amesbury, Massachusetts, USA.
  • Koop D; Avera Research Institute, Rapid City, South Dakota, USA.
  • Petereit MA; Sanford School of Medicine, University of South Dakota, Rapid City, South Dakota, USA.
  • Sargent M; Avera Research Institute, Rapid City, South Dakota, USA.
  • Petereit DG; Monument Health Cancer Care Institute, Rapid City, South Dakota, USA.
Cancer ; 129(24): 3894-3904, 2023 12 15.
Article in En | MEDLINE | ID: mdl-37807694
BACKGROUND: Lung cancer is the leading cause of cancer deaths. Screening individuals who are at elevated risk using low-dose computed tomography reduces lung cancer mortality by ≥20%. Individuals who have community-based factors that contribute to an increased risk of developing lung cancer have high lung cancer rates and are diagnosed at younger ages. In this study of lung cancer in South Dakota, the authors compared the sensitivity of screening eligibility criteria for self-reported Indigenous race and evaluated the need for screening at younger ages. METHODS: US Preventive Services Task Force (USPSTF) 2013 and 2021 (USPSTF2013 and USPSTF2021) criteria and two versions of the PLCOm2012 risk-prediction model (based on the 2012 Prostate, Lung, Colorectal, and Ovarian [PLCO] Cancer Screening Trial), one with a predictor for race and one without, were applied at USPSTF-equivalent thresholds of ≥1.7% in 6 years and ≥1.0% in 6 years to 1565 individuals who were sequentially diagnosed with lung cancer (of whom 12.7% self-reported as Indigenous) at the Monument Health Cancer Care Institute in South Dakota (2010-2019). RESULTS: Eligibility sensitivities of USPSTF criteria did not differ significantly between individuals who self-reported their race as Indigenous and those who did not (p > .05). Sensitivities of both PLCOm2012 models were significantly higher than comparable USPSTF criteria. The sensitivity of USPSTF2021 criteria was 66.1% and, for comparable PLCOm2012 models with and without race, sensitivity was 90.7% and 89.6%, respectively (both p < .001); 1.4% of individuals were younger than 50 years, and proportions did not differ by Indigenous classification (p = .518). CONCLUSIONS: Disparities in screening eligibility were not observed for individuals who self-reported their race as Indigenous. USPSTF criteria had lower sensitivities for lung cancer eligibility. Both PLCOm2012 models had high sensitivities, with higher sensitivity for the model that included race. The PLCOm2012noRace model selected effectively in this population, and screening individuals younger than 50 years did not appear to be justified. PLAIN LANGUAGE SUMMARY: Lung cancer is the leading cause of cancer deaths. Studies show that using low-dose computed tomography scans to screen people who smoke or who used to smoke and are at elevated risk for lung cancer reduces lung cancer deaths. This study of 1565 individuals with lung cancer in South Dakota compared screening eligibility using US Preventive Services Task Force (USPSTF) criteria and a lung cancer risk-prediction model (PLCOm2012; from the 2012 Prostate, Lung, Colorectal, and Ovarian [PLCO] Cancer Screening Trial). The model had higher sensitivity and picked more people with lung cancer to screen compared with USPSTF criteria. Eligibility sensitivities were similar for individuals who self-reported as Indigenous versus those who did not between USPSTF criteria and the model.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Cancer Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States